July 2024 FDA Recall Peg-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate And Ascorbic Acid by Novel Laboratories, Inc. D.b.a Lupin Somerset
D-0628-2024 - Defective container

This Class III drug recall was voluntarily initiated by Novel Laboratories, Inc. D.b.a Lupin Somerset on July 2, 2024 for the product Peg-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate And Ascorbic Acid. The FDA reported the reason for recall as defective container. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0628-2024

Reason for Recall
Defective container: potential for non-sealed pouches which can lead to product leakage.
Initiated
07-02-2024
Reported
08-14-2024
Quantity
13,200 cartons

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Novel Laboratories, Inc. d.b.a Lupin Somerset
Nationwide in the US.
PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution 100g/7.5 g /2.691 g/1.015 g/ 5.9 g / 4.7 g, 3 pouches/carton, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC# 0093-3560-26.

Batch or Lot Expiration Information

Lot# S300542, exp. date June 30, 2025